AU5867901A - Method for detecting tumors - Google Patents

Method for detecting tumors

Info

Publication number
AU5867901A
AU5867901A AU58679/01A AU5867901A AU5867901A AU 5867901 A AU5867901 A AU 5867901A AU 58679/01 A AU58679/01 A AU 58679/01A AU 5867901 A AU5867901 A AU 5867901A AU 5867901 A AU5867901 A AU 5867901A
Authority
AU
Australia
Prior art keywords
detecting tumors
tumors
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU58679/01A
Inventor
Dario Neri
Francesca Viti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Philogen SpA
Original Assignee
Philogen SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philogen SpA filed Critical Philogen SpA
Publication of AU5867901A publication Critical patent/AU5867901A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU58679/01A 2000-05-04 2001-05-03 Method for detecting tumors Abandoned AU5867901A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20186400P 2000-05-04 2000-05-04
US60201864 2000-05-04
PCT/IB2001/000899 WO2001083816A2 (en) 2000-05-04 2001-05-03 Method for detecting tumors

Publications (1)

Publication Number Publication Date
AU5867901A true AU5867901A (en) 2001-11-12

Family

ID=22747609

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58679/01A Abandoned AU5867901A (en) 2000-05-04 2001-05-03 Method for detecting tumors

Country Status (2)

Country Link
AU (1) AU5867901A (en)
WO (1) WO2001083816A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2868618C (en) 2002-10-16 2017-05-23 Gen-Probe Incorporated Compositions and methods for detecting west nile virus
US7927840B2 (en) 2006-09-11 2011-04-19 Gen Probe Incorporated Method for detecting West Nile Virus nucleic acids in the 3′ non-coding region
US7943294B2 (en) 2004-07-30 2011-05-17 Hologic, Inc. Methods for detecting oncofetal fibronectin
BRPI0809989B8 (en) 2007-04-02 2021-05-25 Philogen Spa uses of an antibody or antigen-binding fragment thereof that binds to the extradomain isoform-a (ed-a) of fibronectin and/or to the ed-a of fibronectin
US10202442B2 (en) 2007-07-25 2019-02-12 Philogen S.P.A. Antigen associated with lung cancers and lymphomas
KR102002739B1 (en) 2007-10-30 2019-07-23 필로겐 에스.피.에이. An antigen associated with rheumatoid arthritis
EP2379116B1 (en) 2009-01-07 2015-08-26 Philogen S.p.A. Antigens associated with endometriosis
ES2640981T3 (en) 2009-08-05 2017-11-07 Philogen S.P.A. Selection as a target for bone marrow neovasculature
HUE044927T2 (en) 2012-10-03 2019-11-28 Philogen Spa Antibody conjugate for use in treating inflammatory bowel disease
US20180340936A1 (en) * 2015-11-16 2018-11-29 Hefei Lifeon Pharmaceutical Co. Ltd. Use of ed-b protein in diagnosis of tissue hyperplasia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992015602A1 (en) * 1991-02-28 1992-09-17 Dana-Farber Cancer Institute, Inc. Cancer diagnosis and therapy
WO1997006256A2 (en) * 1995-08-09 1997-02-20 Institut National De La Sante Et De La Recherche Medicale Isolated nucleic acid molecules useful as leukemia markers and in breast cancer prognosis
AU3316600A (en) * 1999-02-22 2000-09-21 Torben F. Orntoft Gene expression in bladder tumors

Also Published As

Publication number Publication date
WO2001083816A3 (en) 2003-03-13
WO2001083816A2 (en) 2001-11-08

Similar Documents

Publication Publication Date Title
AU4277501A (en) Apparatus for detecting defect
AU1232101A (en) Methods for optimizing watermark detection
AU2001227966A1 (en) Methods for treating tumors
AU2651701A (en) Method for introducing additives
AU2002229058A1 (en) Method for estimating signal strengths
AU2002236679A1 (en) Ultrasonic testing system for tubulars
AU2002220898A1 (en) Ligand detection method
AU2001241733A1 (en) Methods for determining single nucleotide variations
AU2001289177A1 (en) Method for determining alleles
AU2001281633A1 (en) Detection method
AUPR050700A0 (en) Detection method
AU5867901A (en) Method for detecting tumors
AUPQ667800A0 (en) Detection method
AU2002323600A1 (en) Method for detecting sepsis
AU2002214487A1 (en) Method for inducing apoptiosis
AU2001295036A1 (en) Apparatus for performing microcurrentelectrotherapy
AU2001281299A1 (en) Methods for automatically detecting gps hardware
AU2001237530A1 (en) Method
AU2002246676A1 (en) Methods for determining organisms
AU2002220757A1 (en) Method for obtaining azaerythromycin
AU2001241636A1 (en) Halotherapy method
AU2001232231A1 (en) Method for detecting substance
AU2001283197A1 (en) Method for detecting plug wear
AU6138500A (en) Method for measuring loss
AU2001217349A1 (en) Apparatus for parking lot

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase